Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CFG
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 858.01 -553.48 57.77
Graham Fair Price 32.73 28.96 21.82
PEG -61.61 0.13 -0.34
Price/Book 9.02 0.69 0.63
Price/Cash Flow 77.46 44.08 24.84
Prices/Earnings -39.78 12.31 20.44
Price/Sales -33.16 5.20 7.77
Price/FCF 77.46 44.08 24.84
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -0.20 0.99 0.99
Operating Margin 55.41 0.14 0.09
ROA 77.93 < 0.005 < 0.005
ROE < 0.005 0.01 81.04
ROIC < 0.005 < 0.005 112.56
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.01 -0.21 94.46
Dividends QOQ < 0.005 < 0.005 -31.64
EBIT QOQ -0.68 1.47 116.41
EPS QOQ -0.60 0.94 56.86
FCF QOQ -0.36 -0.40 -10.57
Revenue QOQ -0.01 0.59 4486.13
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) -105104.84 0.00 inf
Days Sales Outstanding (DSO) 50.79 0.00 inf
Inventory Turnover < 0.005 0.00 inf
Debt/Capitalization 0.36 0.37 0.81
Quick Ratio 84.80 0.47 -99.44
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 52.21 51.50 -1.36
Cash 89.44 93.42 4.44
Capex -0.10 -0.02 78.95
Free Cash Flow 1.33 0.81 -39.40
Revenue 4.26 6.86 60.89
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 84.80 0.14 -99.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.44 -55.21 757.08
Naive Interpretation Member
06 - Financial Health · Bad